Ftse Mib
34.335,29
0,44%
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
97.053,61
2,82%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ EyePoint Pharmaceuticals Inc (EYPT) EyePoint Pharmaceuticals Inc (EYPT) Notizie

EyePoint Pharmaceuticals Inc

EYPT
8,03
0,58 (7,79%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202413:00GLOBEEyePoint to Present at the 43rd Annual J.P. Morgan..
16/12/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
04/12/202413:05EDGAR2Form 8-K - Current report
04/12/202413:00GLOBEEyePoint Announces First Patient Dosed in Second Global..
18/11/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
14/11/202421:10EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:05EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEEyePoint Pharmaceuticals Reports Third Quarter 2024..
04/11/202413:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
31/10/202421:16EDGAR2Form 8-K - Current report
31/10/202421:00GLOBEEyePoint Pharmaceuticals Announces Closing of Upsized Public..
30/10/202421:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/10/202402:47GLOBEEyePoint Pharmaceuticals Announces Pricing of Upsized Public..
28/10/202422:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/10/202422:14GLOBEEyePoint Pharmaceuticals Announces Proposed Public Offering..
28/10/202412:05EDGAR2Form 8-K - Current report
28/10/202412:00GLOBEEyePoint Pharmaceuticals Announces Positive Interim 16-Week..
24/10/202413:05EDGAR2Form 8-K - Current report
24/10/202413:00GLOBEEyePoint Pharmaceuticals Announces First Patient Dosed in..
22/10/202421:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
16/10/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
16/9/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
04/9/202413:05EDGAR2Form 8-K - Current report
04/9/202413:00GLOBEEyePoint Pharmaceuticals Appoints Esteemed Industry Leader..
27/8/202413:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
21/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
16/8/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
08/8/202422:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:42EDGAR2Form S-3 - Registration statement under Securities Act of..
08/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:00GLOBEEyePoint Pharmaceuticals to Present at the H.C. Wainwright..
07/8/202413:00EDGAR2Form 8-K - Current report
07/8/202413:00GLOBEEyePoint Pharmaceuticals Reports Second Quarter 2024..
26/7/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
12/7/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/6/202414:00GLOBEEyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib..
18/6/202413:00GLOBEEyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
17/6/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
05/6/202413:00GLOBEEyePoint Pharmaceuticals to Present at Goldman Sachs 45th..
28/5/202413:05EDGAR2Form 8-K - Current report
16/5/202413:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
09/5/202416:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202413:05EDGAR2Form 8-K - Current report
Apertura: 7,59 Min: 7,5445 Max: 8,42
Chiusura: 7,45

La tua Cronologia

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network